Nobel Winner Raised Safety Concerns About Only “Modestly” Effective mRNA Vaccines
Weissman specifically pointed to risks of autoimmune reactions and “pathological thrombus formation” – or blood-clotting – which have become all-too-familiar in the intervening years since vaccine rollout.